NRC
TMO icon

New Republic Capital’s Thermo Fisher Scientific TMO Stock Holding History

New Republic Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$722K Buy
1,438
+188
+15% +$90.3K 0.17% 107
2026
Q1 		$615K Sell
1,250
-808
-39% -$439K 0.21% 87
2025
Q4 		$1.19M Buy
2,058
+1,166
+131% +$659K 0.32% 63
2025
Q3 		$433K Buy
892
+162
+22% +$75.4K 0.13% 102
2025
Q2 		$296K Sell
730
-110
-13% -$46K 0.1% 133
2025
Q1 		$418K Buy
840
+13
+2% +$7.04K 0.18% 91
2024
Q4 		$431K Sell
827
-119
-13% -$65.4K 0.28% 85
2024
Q3 		$586K Sell
946
-172
-15% -$102K 0.34% 64
2024
Q2 		$619K Buy
1,118
+163
+17% +$93.4K 0.31% 64
2024
Q1 		$555K Buy
955
+126
+15% +$70.7K 0.35% 69
2023
Q4 		$440K Buy
829
+143
+21% +$69.2K 0.31% 79
2023
Q3 		$347K Sell
686
-62
-8% -$33K 0.28% 78
2023
Q2 		$390K Buy
748
+28
+4% +$15.1K 0.27% 75
2023
Q1 		$415K Buy
720
+94
+15% +$53K 0.31% 63
2022
Q4 		$345K Buy
+626
New +$332K 0.27% 67

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

New Republic Capital's TMO Position: Q2 2026 in Review

New Republic Capital increased its Thermo Fisher Scientific (TMO) stake by 15% in Q2 2026, buying an estimated $90.3K and bringing the position to 1,438 shares worth $722K. The position accounts for 0.17% of the portfolio, ranked #107.

New Republic Capital first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.19M in Q4 2025. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • New Republic Capital held 1,438 shares of Thermo Fisher Scientific worth $722K as of Q2 2026.
  • New Republic Capital bought 188 Thermo Fisher Scientific shares in Q2 2026, an estimated $90.3K.
  • Thermo Fisher Scientific made up 0.17% of New Republic Capital's portfolio in Q2 2026, its #107 holding.
  • New Republic Capital first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
  • New Republic Capital's Thermo Fisher Scientific position peaked at $1.19M in Q4 2025.
  • 2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on New Republic Capital's 13F filing for Q2 2026, filed 31 Jul 2026.